![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
References
- Agnoli A. Clinical and psychometric aspects of the therapeutic effects of GBE. Effects of GBE and Organic Cerebral Impairment. Libbey, Paris, London 19851. Agnoli A. Clinical and psychometric aspects of the therapeutic effects of GBE. Effects of GBE and Organic Cerebral Impairment. Libbey, Paris, London 1985
- Allard M. Treatment of old age disorders with Ginkgo biloba extract. Rökan (Ginkgo biloba). Recent Results in Pharmacology and Clinic. E. W. Fünfgeld Springer-Verlag, Berlin, Heidelberg, New York 1988; 201–2112. Allard M. Treatment of old age disorders with Ginkgo biloba extract. Rökan (Ginkgo biloba). Recent Results in Pharmacology and Clinic. E. W. Fünfgeld Springer-Verlag, Berlin, Heidelberg, New York 1988; 201–211
- Chaterjee S. S., Garbard B. Protective effect of an extract of Ginkgo biloba and other hydroxyl radical scavengers against hypoxia. Proc. VII Int. Congress Pharmacol., Tokyo, 1981, Abstract 8663. Chaterjee S. S., Garbard B. Protective effect of an extract of Ginkgo biloba and other hydroxyl radical scavengers against hypoxia. Proc. VII Int. Congress Pharmacol., Tokyo, 1981, Abstract 866
- Drieu K. Preparation and definition of Ginkgo biloba extract. Rökan (Ginkgo biloba). Recent Results in Pharmacology and Clinic. E. W. Fünfgeld Springer-Verlag, Berlin, Heidelberg, New York 1988; 32–364. Drieu K. Preparation and definition of Ginkgo biloba extract. Rökan (Ginkgo biloba). Recent Results in Pharmacology and Clinic. E. W. Fünfgeld Springer-Verlag, Berlin, Heidelberg, New York 1988; 32–36
- Leroy H., Salaun P., Chovelon R., Bouilloux E. Approche clinique et psycho-métrique en gériatrie. Méthodes d'etudes et choix d'une thérapeutique. Vie Medicale 1978; 19: 2513–25195. Leroy H., Salaun P., Chovelon R., Bouilloux E. Approche clinique et psycho-métrique en gériatrie. Méthodes d'etudes et choix d'une thérapeutique. Vie Medicale 1978; 19: 2513–2519
- McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadman E. Clinical diagnosis of Alzheimers Disease: Report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimers Disease. Neurology 1984; 34: 939–9446. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadman E. Clinical diagnosis of Alzheimers Disease: Report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimers Disease. Neurology 1984; 34: 939–944
- Pidoux B., Bastein C., Niddam S. Clinical and quantitative EEG double-blind study of GBE. J. Cerebral Blood Flow Metab. 1983; 3: 5556–55577. Pidoux B., Bastein C., Niddam S. Clinical and quantitative EEG double-blind study of GBE. J. Cerebral Blood Flow Metab. 1983; 3: 5556–5557
- Subhan Z., Hindmarch I. The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int. J. Clin. Pharmacol. Res. 1984; 4: 89–938. Subhan Z., Hindmarch I. The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int. J. Clin. Pharmacol. Res. 1984; 4: 89–93
- Tea S., Celsis P., Clanet M., Marc-Vergnes J. P. Effets clinique, haemo-dynamique et metabolique de l'extrait de Ginkgo biloba en pathologie cerebrale. Gaz. Med. Fr. 1979; 86: 41499. Tea S., Celsis P., Clanet M., Marc-Vergnes J. P. Effets clinique, haemo-dynamique et metabolique de l'extrait de Ginkgo biloba en pathologie cerebrale. Gaz. Med. Fr. 1979; 86: 4149
- Wesnes K., Simmons D., Rook M., Simpson P. A double-blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Human Psychopharmacol 1987; 2: 159–16910. Wesnes K., Simmons D., Rook M., Simpson P. A double-blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Human Psychopharmacol 1987; 2: 159–169